Technology | Magnetic Resonance Imaging (MRI) | December 21, 2015

Philips Unveils First MRI Automated User Interface

Technology designed to simplify exams in patients with MR conditional implants
 

Philips, ScanWise Implant, MRI, MR conditional implants, RSNA 2015

December 21, 2015 — Philips Healthcare introduced ScanWise Implant, the industry’s first magnetic resonance imaging (MRI)-guided user interface and automatic scan parameter selection, at the 2015 Radiological Society of North America (RSNA) annual meeting. The interface is designed to help simplify the scanning of patients with MR conditional implants, such as knee and hip replacements, spine implants, pacemakers and implantable defibrillators.

The new software helps users streamline exams and supports diagnostic confidence of this growing patient population.

MRI is a modality of choice for diagnosing conditions such as neurological disorders, cancer, and muscle, joint and back pain. These conditions are most prevalent in older patient populations, and the population with large joint replacements and implanted cardiac devices is expected to increase by about 70 percent over the next five years.

However, implants can create a number of challenges with MRI exams. For example, it is difficult for clinicians to understand and scan within the safety limits defined by each implant manufacturer. These limits are not always clear or easy to implement on the MR scanner, causing patients with MR conditional implants to often be denied MRI exams.

Introducing MRI to a patient’s diagnostic and treatment plan allows clinicians enhanced accuracy and improved workflow, and provides patients with access to better care. According to Harald Kugel, Ph.D., Department of Clinical Radiology, University of Münster, “The previous industry standard was: if patients had an implant, they couldn’t be examined with MR. However, patients deserve the best imaging modality available and shouldn’t be excluded from a modality, because risks aren’t truly known and documented. It’s a milestone achievement that Philips developed an answer for patients with conditional implants to have access to MRIs.”

“From a technologist’s perspective, we’re excited about the prospect of shortening exam times and broadening the diagnostic modalities available for those patients with MR conditional implants,” said Scott Hipko, chief MRI research technologist, The University of Vermont, College of Medicine. “Philips understands the needs of radiologists and brings the expertise needed to create a smart solution to help guide operators to meet the specific criteria for each implant.”

ScanWise Implant is the newest addition to Philips’ advanced diagnostic imaging solutions designed to support first-time-right imaging. Other products within this portfolio include:

  • Ingenia 1.5T S, which is designed for first-time-right imaging and increased patient comfort for a faster workflow;
  • mDIXON XD, which provides fast, sharp and fat-free imaging for all anatomies, increasing the diagnostic information by providing two contrasts in a single scan; and
  • Philips’ MR in-bore experience, which helps to improve the patient experience and utilizes AutoVoice and ComforTone to turn the patient exam into an event.

For more information: www.philips.com

Related Content

Videos | Computed Tomography (CT) | July 19, 2019
Quynh Truong, M.D., MPH, associate professor of radio
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Fluke Biomedical Introduces RaySafe 452 Survey Meter
Technology | Radiation Dose Management | July 11, 2019
Radiation measurement often requires different devices for varying applications, adding to the cost and complexity of...
Mednax National Cardiac Centers of Excellence Program Highlighted at SCCT 2019
News | CT Angiography (CTA) | July 11, 2019
Mednax Inc. and Mednax Radiology Solutions announced that Chief Medical Officer Ricardo C. Cury, M.D., FSCCT, will...
360 Photos | Ultrasound Imaging | July 11, 2019
This 360 degree photo shows a basic, point-of-care cardiac echocardiogram being performed using a smartphone turned i
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Achenbach to Receive Inaugural 2019 Stephan Achenbach Pioneer Award in Cardiovascular CT
News | Cardiac Imaging | July 10, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present Stephan Achenbach, M.D., FSCCT with the inaugural...